Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42226 (
Signal transducer and activator of transcription 6
)
35
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Signal transducer and activator of transcription 6
(
Stat6
) and NF-kappaB are widely distributed transcription factors which are induced by different stimuli and bind to distinct DNA sequence motifs. Interleukin-4 (IL-4), which activates
Stat6
, synergizes with activators of NF-kappaB to induce IL-4-responsive genes, but the molecular mechanism of this synergy is poorly understood. Using
glutathione S-transferase
pulldown assays and coimmunoprecipitation techniques, we find that NF-kappaB and tyrosine-phosphorylated
Stat6
can directly bind each other in vitro and in vivo. An IL-4-inducible reporter gene containing both cognate binding sites in the promoter is synergistically activated in the presence of IL-4 when
Stat6
and NF-kappaB proteins are coexpressed in human embryonic kidney 293 (HEK 293) cells. The same IL-4-inducible reporter gene is also synergistically activated by the endogenous
Stat6
and NF-kappaB proteins in IL-4-stimulated I.29mu B lymphoma cells. Furthermore,
Stat6
and NF-kappaB bind cooperatively to a DNA probe containing both sites, and the presence of a complex formed by their cooperative binding correlates with the synergistic activation of the promoter by
Stat6
and NF-kappaB. We conclude that the direct interaction between
Stat6
and NF-kappaB may provide a basis for synergistic activation of transcription by IL-4 and activators of NF-kappaB.
...
PMID:Interaction of stat6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription. 958 80
Signal transducer and activator of transcription 6
(
STAT6
) regulates transcriptional activation in response to interleukin-4 (IL-4)-induced tyrosine phosphorylation by direct interaction with coactivators. The CREB-binding protein and the nuclear coactivator 1 (NCoA-1), a member of the p160/steroid receptor coactivator family, bind independently to specific regions of
STAT6
and act as coactivators. In this study we show that an LXXLL motif in the
STAT6
transactivation domain mediates the interaction with NCoA-1. Peptides representing this motif as well as antibodies generated against this motif inhibited
STAT6
/NCoA-1 interaction in
glutathione S-transferase
pulldown assays. Peptides derived from the
STAT6
transactivation domain adjacent to the LXXLL motif as well as antibodies against these peptides showed no inhibitory effect. Mutagenesis of the LXXLL motif eliminated the
STAT6
/NCoA-1 interaction in vitro and in vivo, supporting the specific role of this motif in NCoA-1 binding. Importantly, mutagenesis of the STAT-LXXLL motif strongly diminished the IL-4-regulated activation of the endogenous
STAT6
target gene eotaxin-3. Taken together, these results indicate that the
STAT6
-LXXLL-binding motif mediates the interaction with NCoA-1 in transcriptional activation and represents a new potential drug target for the inhibition of the
STAT6
transactivation function in allergic diseases.
...
PMID:An LXXLL motif in the transactivation domain of STAT6 mediates recruitment of NCoA-1/SRC-1. 1213 96